Engelhard, Matthew M.
Kollins, Scott H.
Article History
First Online: 13 August 2019
Compliance with Ethical Standards
:
: Matthew M. Engelhard declares no potential conflicts of interest.Scott H. Kollins reports grants and personal fees from Akili Interactive, Arbor Pharmaceuticals, Bose, Otsuka Pharmaceuticals, Rhodes, Shire Pharmaceuticals, and Tris Pharmaceuticals.
: This article does not contain any studies with human or animal subjects performed by any of the authors.